Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +71.67%
#3 Pons Pons +29.07%
#4 MetaDAO MetaDAO +29.01%
#5 Rain Rain +22.48%
#6 Bedrock Bedrock +20.15%
#7 Ontology Gas Ontology Gas +15.99%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.96%
#9 Humanity Humanity +14.86%
#10 Prom Prom +14.40%
Coin of the day
QuantixAI QuantixAI
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Classificação em ações #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Preço da ação
$4.06
Última sincronização: 2024-02-23
Valor de mercado
$145.61M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Theseus Pharmaceuticals, Inc. (THRX)

Categoria

Healthcare
Lucros da Theseus Pharmaceuticals, Inc. (THRX)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Theseus Pharmaceuticals, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Theseus Pharmaceuticals, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH